The proposed order settling the FTC’s complaint prohibits the defendants from making health claims, including claims that their products can alleviate withdrawal symptoms or help with drug dependency, unless the claims are non-misleading and are substantiated by scientific evidence. The terms of the order are very similar to those in the FTC’s recent case against Sunrise Nutraceuticals, another company that the FTC alleged lacked the necessary scientific evidence to prove its herbal product helped with opiate withdrawal.
Finally, the proposed order imposes a $6.6 million judgment against the defendants, which will be suspended based on their inability to pay.
The Commission vote authorizing the staff to file the complaint and to approve the stipulated proposed order was 2-0. The FTC filed the complaint and proposed order in the U.S. District Court for the Western District of Texas.
NOTE: The Commission files a complaint when it has “reason to believe” that the law has been or is being violated and it appears to the Commission that a proceeding is in the public interest. Stipulated court orders have the force of law when approved and signed by the District Court judge.
The Federal Trade Commission works to promote competition, and protect and educate consumers. You can learn more about consumer topics and file a consumer complaint online or by calling 1-877-FTC-HELP (382-4357). Like the FTC on Facebook, follow us on Twitter, read our blogs and subscribe to press releases for the latest FTC news and resources.
Contact Information
MEDIA CONTACT:
Mitchell J. Katz
Office of Public Affairs
202-326-2161
STAFF CONTACT:
Edward Glennon
Bureau of Consumer Protection
202-326-3126
Related Case
Catlin Enterprises, Inc.
For Consumers
Blog: Dealing with opiate withdrawal
Dietary Supplements
For Businesses
Blog: FTC challenges claims for opiate withdrawal products
More news from the FTC >>
No.2 主 さくら
17/05/05 22:22:49
The proposed order settling the FTC’s complaint prohibits the defendants from making health claims, including claims that their products can alleviate withdrawal symptoms or help with drug dependency, unless the claims are non-misleading and are substantiated by scientific evidence. The terms of the order are very similar to those in the FTC’s recent case against Sunrise Nutraceuticals, another company that the FTC alleged lacked the necessary scientific evidence to prove its herbal product helped with opiate withdrawal.
Finally, the proposed order imposes a $6.6 million judgment against the defendants, which will be suspended based on their inability to pay.
The Commission vote authorizing the staff to file the complaint and to approve the stipulated proposed order was 2-0. The FTC filed the complaint and proposed order in the U.S. District Court for the Western District of Texas.
NOTE: The Commission files a complaint when it has “reason to believe” that the law has been or is being violated and it appears to the Commission that a proceeding is in the public interest. Stipulated court orders have the force of law when approved and signed by the District Court judge.
The Federal Trade Commission works to promote competition, and protect and educate consumers. You can learn more about consumer topics and file a consumer complaint online or by calling 1-877-FTC-HELP (382-4357). Like the FTC on Facebook, follow us on Twitter, read our blogs and subscribe to press releases for the latest FTC news and resources.
Contact Information
MEDIA CONTACT:
Mitchell J. Katz
Office of Public Affairs
202-326-2161
STAFF CONTACT:
Edward Glennon
Bureau of Consumer Protection
202-326-3126
Related Case
Catlin Enterprises, Inc.
For Consumers
Blog: Dealing with opiate withdrawal
Dietary Supplements
For Businesses
Blog: FTC challenges claims for opiate withdrawal products
More news from the FTC >>
通報
コメント
古トピの為、これ以上コメントできません
返信コメント
まだコメントがありません